CD8A and neoplasm: The efficacy of glutamine antagonism was entirely dependent on the activity of CD8 T cells, indicating that the mechanism through which glutamine antagonism promoted anti-tumoral activity was through enhancing cytotoxic T cell anti-tumor response [51].